Phase II trial of imatinib mesylate in recurrent, biomarker positive, ovarian cancer (Southwest Oncology Group Protocol S0211). (Q38506719)
Jump to navigation
Jump to search
scientific article published on 05 March 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of imatinib mesylate in recurrent, biomarker positive, ovarian cancer (Southwest Oncology Group Protocol S0211). |
scientific article published on 05 March 2007 |
Statements
1 reference
Phase II trial of imatinib mesylate in recurrent, biomarker positive, ovarian cancer (Southwest Oncology Group Protocol S0211). (English)
1 reference
Alberts DS
1 reference
Liu PY
1 reference
Wilczynski SP
1 reference
Jang A
1 reference
Moon J
1 reference
Ward JH
1 reference
Beck JT
1 reference
Clouser M
1 reference
Markman M
1 reference
5 March 2007
1 reference
1 reference
17
1 reference
4
1 reference
784-788
1 reference
Identifiers
1 reference
1 reference